4/20
01:00 am
artv
Low
Report
4/15
06:19 pm
artv
Artiva Biotherapeutics Spotlights RA as Lead NK Cell Program, Eyes H1 Efficacy Data Catalyst at Needham [Yahoo! Finance]
High
Report
Artiva Biotherapeutics Spotlights RA as Lead NK Cell Program, Eyes H1 Efficacy Data Catalyst at Needham [Yahoo! Finance]
4/12
01:00 am
artv
Medium
Report
4/8
08:00 am
artv
Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
High
Report
Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
4/4
01:05 am
artv
Medium
Report
3/11
08:03 am
artv
Artiva Biotherapeutics (ARTV) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $18.00 price target on the stock.
Medium
Report
Artiva Biotherapeutics (ARTV) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $18.00 price target on the stock.
3/10
05:22 pm
artv
Artiva Biotherapeutics GAAP EPS of -$3.43 [Seeking Alpha]
High
Report
Artiva Biotherapeutics GAAP EPS of -$3.43 [Seeking Alpha]
3/10
04:23 pm
artv
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
High
Report
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
3/10
04:05 pm
artv
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
High
Report
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
3/4
03:32 pm
artv
Artiva Biotherapeutics Pivots to Rheumatoid Arthritis at TD Cowen, Teases 2026 RA Data Update [Yahoo! Finance]
Low
Report
Artiva Biotherapeutics Pivots to Rheumatoid Arthritis at TD Cowen, Teases 2026 RA Data Update [Yahoo! Finance]
3/3
08:06 am
artv
Latigo Biotherapeutics Appoints Neha Krishnamohan as Chief Financial Officer and Chief Business Officer [Yahoo! Finance]
Low
Report
Latigo Biotherapeutics Appoints Neha Krishnamohan as Chief Financial Officer and Chief Business Officer [Yahoo! Finance]
2/25
08:25 am
artv
Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/25
08:00 am
artv
Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
Low
Report
Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
2/24
08:00 am
artv
Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant
Medium
Report
Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant
2/19
08:00 am
artv
Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors
Medium
Report
Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors
1/29
06:16 am
artv
Artiva Biotherapeutics (NASDAQ:ARTV) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Artiva Biotherapeutics (NASDAQ:ARTV) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/21
10:32 am
artv
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability
Low
Report
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability
1/21
08:00 am
artv
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability
Medium
Report
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability